封面
市场调查报告书
商品编码
2016206

辐射剂量管理市场:按产品、交付方式、应用和最终用户划分-2026-2032年全球市场预测

Radiation Dose Management Market by Product, Delivery Mode, Application, End User - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年,辐射剂量管理市场价值将达到 3.6312 亿美元,到 2026 年将成长至 3.8734 亿美元,到 2032 年将达到 6.1767 亿美元,复合年增长率为 7.88%。

主要市场统计数据
基准年 2025 3.6312亿美元
预计年份:2026年 3.8734亿美元
预测年份:2032年 6.1767亿美元
复合年增长率 (%) 7.88%

本文件阐明了临床工作流程、技术整合和监管课责中辐射剂量管理的现代要求,从而提高病患安全和影像品质。

辐射剂量管理涉及病人安全、影像有效性和监管课责三者。影像硬体的进步、软体主导的剂量监测工具的普及以及循证方案日益重要,共同建构了一个复杂的生态系统,临床医生、物理学家和管理人员必须通力合作,才能优化治疗效果。本文概述了现代实践的核心主题:整合剂量管理系统的成熟、云端原生分析技术的兴起以及对厂商互通性的日益重视,以实现持续的品质改进。

人工智慧、云端分析和互通性的进步如何重塑辐射剂量优化和临床实践,从而推动更安全、更聪明的成像工作流程?

辐射剂量管理领域正经历一场变革,其驱动力包括技术融合、政策日益重视以及不断变化的临床需求。儘管CT硬体和检测器灵敏度的提升降低了许多扫描方案的最低可达剂量,但真正的革命在于软体主导的剂量最佳化。人工智慧和机器学习工具正越来越多地应用于扫描方案选择、影像重建和自动剂量估算,从而实现自适应成像策略,即使在较低的辐射剂量下也能保持诊断价值。

评估 2025 年美国关税调整对剂量管理采购趋势、供应链韧性和供应商服务模式的策略影响。

2025年实施的新关税措施对辐射剂量管理生态系统中的技术应用、供应商策略和供应链韧性造成了直接和间接的压力。某些零件和系统的进口成本上升迫使供应商重新评估製造地、加速本地化策略并重新协商分销模式。对于医疗服务提供者而言,由于采购团队需要在总拥有成本、短期资金限制和长期营运效益之间权衡,采购週期正在延长。

我们针对不同产品、输送方式、临床应用和最终用户环境,识别辐射剂量管理的具体挑战,并制定针对每种情况的实施策略。

精确理解剂量分割对于优化剂量管理策略以适应临床和操作环境至关重要。根据产品类型,研究通常将产品分为服务、软体和系统。服务包括校准、合规性、维护(对员工能力至关重要)、培训和咨询。软体分为云端部署和本地部署,反映了对集中化、延迟和资料主权的不同需求。系统进一步分为CT、乳房X光乳房X光摄影以及X光和透视设备,每种设备都有其独特的剂量分布和优化途径。

美洲、欧洲、中东和非洲以及亚太地区的地理差异如何影响剂量管理的实施模式、监管重点和服务提供模式。

区域趋势对辐射剂量管理领域的技术应用、监管合规和服务模式有显着影响。在美洲,医疗机构倾向于优先考虑符合严格监管报告和认证要求的整合解决方案,而公立和私人保险公司则越来越重视可验证的安全性能。这推动了对可互操作系统、全面维护合约以及支援临床管治和营运效率的分析能力的需求。大都会圈的领先医疗中心往往是推动新型剂量优化技术应用的催化剂。

竞争格局分析,重点在于那些将设备创新、互通软体和强大的服务模式相结合,以促进辐射安全和营运弹性的供应商。

辐射剂量管理生态系统中的主要企业正在部署一系列整合系统、专用软体和服务,优先考虑安全性、互通性和全生命週期支援。市场领导者正加大研发投入,以推进剂量降低技术、整合人工智慧驱动的重建演算法并增强远端监控能力,从而减少停机时间并提高校准精度。系统製造商、软体供应商和服务供应商之间的策略伙伴关係正成为提供端到端解决方案的常见方式,这些解决方案将设备级控制与企业级分析相结合。

为了优化辐射剂量管理,医疗保健管理者需要采取切实可行的、优先的行动,协调采购、训练、互通性和管治。

业界领导者必须推动一系列切实可行的倡议,以加速医疗机构辐射剂量管理的实质改进。优先投资于员工培训和系统咨询至关重要,这有助于将剂量意识融入日常影像工作流程,并支援持续改善操作规程。培训项目应着重实用性,并针对具体职位进行调整,同时透过能力评估和定期审核来强化训练效果。

采用综合混合方法研究方法,结合专家访谈、技术评估和监管分析,以支持研究结果的检验和实际应用。

本研究采用混合方法,结合质性专家访谈、技术评估、监管审查和二手文献整合,以确保方法的严谨性和有效性。关键输入包括对临床负责人、医学物理学家、影像技师和采购负责人的结构化访谈,以收集关于可用性、培训需求和操作限制的实际观点。这些见解与产品文件、临床指南和同行评审的研究进行交叉比对,以检验技术声明和性能特征。

将策略重点和实际途径结合,使辐射剂量管理成为临床品质、安全和营运韧性的可持续组成部分。

辐射剂量管理如今已成为一项策略性挑战,它关係到临床品质、病人安全和组织韧性。先进成像硬体、人工智慧驱动的最佳化以及可扩展的分析技术的整合,为在维持和提升诊断效果的同时减少不必要的辐射暴露提供了契机。然而,要充分发挥这一潜力,需要重视人力资源发展、互通性、生命週期服务模式以及能够保护病患资料并确保合规性的管治框架。

目录

第一章:序言

第二章:调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵,2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章:美国关税的累积影响,2025年

第七章:人工智慧的累积影响,2025年

第八章 辐射剂量管理市场:依产品划分

  • 服务
    • 维护
    • 培训和咨询
  • 软体
    • 现场
  • 系统
    • CT
    • 乳房X光摄影
    • X射线和透视

第九章:辐射剂量管理市场:依交付模式划分

  • 现场

第十章 辐射剂量管理市场:依应用领域划分

  • 牙科影像
  • 诊断影像
  • 介入治疗
  • 放射治疗

第十一章 辐射剂量管理市场:依最终用户划分

  • 诊所
  • 诊断中心
  • 医院
  • 研究机构

第十二章:辐射剂量管理市场:依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章:辐射剂量管理市场:依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 辐射剂量管理市场:依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章:美国辐射剂量管理市场

第十六章:中国辐射剂量管理市场

第十七章 竞争格局

  • 市场集中度分析,2025年
    • 浓度比(CR)
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析,2025 年
  • 2025年产品系列分析
  • 基准分析,2025 年
  • Agfa HealthCare NV
  • Bayer AG
  • Bracco Imaging SpA
  • Canon Inc.
  • FUJIFILM Holdings Corporation
  • GE HealthCare LLC
  • Guerbet SA
  • INFINITT Healthcare Co., Ltd.
  • Koninklijke Philips NV
  • Landauer, Inc.
  • Medsquare SA
  • Mirion Technologies, Inc.
  • Novarad Corporation
  • PACSHealth, LLC
  • Siemens Healthineers AG
Product Code: MRR-035AB9C0DA67

The Radiation Dose Management Market was valued at USD 363.12 million in 2025 and is projected to grow to USD 387.34 million in 2026, with a CAGR of 7.88%, reaching USD 617.67 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 363.12 million
Estimated Year [2026] USD 387.34 million
Forecast Year [2032] USD 617.67 million
CAGR (%) 7.88%

Framing the contemporary imperative for radiation dose management across clinical workflows, technology convergence, and regulatory accountability to enhance patient safety and imaging quality

Radiation dose management sits at the intersection of patient safety, imaging efficacy, and regulatory accountability. Advances in imaging hardware, the proliferation of software-driven dose monitoring tools, and the increasing emphasis on evidence-based protocols have created a complex ecosystem where clinicians, physicists, and administrators must collaborate to optimize outcomes. This introduction outlines the core themes that underpin contemporary practice: the maturation of integrated dose management systems, the rise of cloud-native analytics, and the intensifying focus on cross-vendor interoperability to enable continuous quality improvement.

Within clinical environments, the practical imperative is clear: reduce unnecessary exposure while preserving diagnostic confidence. This necessitates converging investments in staff training, robust maintenance programs, and software solutions that deliver real-time feedback. Meanwhile, vendor strategies are evolving to embed dose tracking within broader imaging informatics platforms, enabling longitudinal patient dose histories and population-level analytics. The pace of innovation is matched by evolving standards and guidelines that emphasize transparency, documentation, and actionable alerts when thresholds are exceeded.

Consequently, leaders in healthcare delivery and medical technology must balance technological possibilities with operational realities. This report provides a foundation for understanding where emerging technologies can be deployed for maximal clinical benefit, where workflow redesign is required, and how stakeholders can collaborate to sustain improvements in radiation safety and diagnostic quality.

How advances in AI, cloud analytics, and interoperability are reshaping radiation dose optimization and clinical practice to drive safer, smarter imaging workflows

The landscape of radiation dose management is undergoing transformative shifts driven by technological convergence, policy emphasis, and changing clinical expectations. Advancements in CT hardware and detector sensitivity have reduced the minimum achievable dose for many protocols, yet the real revolution lies in software-driven dose optimization. Artificial intelligence and machine learning tools are increasingly applied to protocol selection, image reconstruction, and automated dose estimation, enabling adaptive imaging strategies that maintain diagnostic value at lower exposure levels.

Simultaneously, the migration of analytics to cloud architectures has unlocked scalable population-level insights, permitting longitudinal dose tracking across institutions and care episodes. This shift supports benchmarking, trend analysis, and predictive maintenance programs that reduce unplanned downtime and preserve calibration integrity. Interoperability standards and APIs are maturing, facilitating the integration of dose monitoring into electronic health records and vendor-neutral archives, which bolsters clinical decision support and recordkeeping.

In parallel, workforce competencies are adapting. Radiographers, medical physicists, and radiologists increasingly require fluency with dose analytics, protocol governance, and change management practices. Training and consultancy services are expanding to meet these needs, emphasizing practical implementation, audit readiness, and cultural change toward dose awareness. Taken together, these transformative forces are reshaping how institutions approach safety, efficiency, and accountability in medical imaging.

Assessing the strategic consequences of United States tariff adjustments in 2025 on procurement dynamics, supply chain resilience, and vendor service models in dose management

The introduction of new tariff policies in the United States in 2025 has introduced direct and indirect pressures on technology acquisition, supplier strategies, and supply chain resilience within the radiation dose management ecosystem. Increased import costs for certain components and systems have incentivized vendors to reassess manufacturing footprints, accelerate localization strategies, and renegotiate distribution models. For healthcare providers, procurement cycles have lengthened as purchasing teams weigh total cost of ownership against immediate capital constraints and long-term operational benefits.

Regulatory and reimbursement frameworks have responded by placing greater emphasis on demonstrable value and lifecycle support. Organizations are prioritizing solutions that offer robust maintenance plans, remote diagnostics, and software upgrades that can extend equipment longevity and mitigate the need for frequent capital replacement. Cloud-based software licensing models and service contracts have become more attractive as they decouple upfront hardware costs from ongoing analytics and support, though they require due diligence around data governance and cybersecurity.

Vendors and providers alike are exploring alternative pathways to manage tariff impacts, such as strategic partnerships, regional service hubs, and modular upgrade offerings that isolate high-cost components from the overall system. These adaptations reflect a broader shift toward resilience and flexibility, ensuring that the capacity to deliver safe, high-quality imaging services remains intact despite external economic pressures.

Segment-specific imperatives in radiation dose management across products, delivery modes, clinical applications, and end-user settings to guide tailored adoption strategies

A nuanced understanding of segmentation is essential for tailoring dose management strategies to clinical and operational contexts. Based on product, studies typically classify offerings across services, software, and system categories. Services encompass maintenance and training and consultancy, which are critical for sustaining calibration, compliance, and staff competency. Software divides into cloud-based and on-premise deployments, reflecting divergent needs for centralization, latency, and data sovereignty. Systems are further categorized into CT, mammography, and X-ray and fluoroscopy, each with unique dose profiles and optimization pathways.

Based on delivery mode, distinctions between cloud-based and on-premise solutions determine integration complexity, data stewardship responsibilities, and scalability potential. Cloud-based offerings accelerate population-level analytics and centralized updates but require mature cybersecurity and consent frameworks. On-premise deployments provide tighter control over data residency and may better suit institutions with constrained connectivity or heightened regulatory requirements.

Based on application, clinical use cases span dental imaging, diagnostic imaging, interventional procedures, and radiotherapy, each demanding bespoke dose tracking, protocol optimization, and outcome measurement. Dental imaging often focuses on focused low-dose protocols and pediatric considerations, while interventional procedures require real-time dose monitoring and operator alerts. Radiotherapy integrates dosimetry with treatment planning systems, necessitating high-precision measurements and harmonized workflows.

Based on end user, the typical settings include clinics, diagnostic centers, hospitals, and research institutes, each with different purchasing dynamics, operational scale, and regulatory expectations. Clinics and diagnostic centers prioritize cost-effective, easy-to-deploy solutions that minimize disruption. Hospitals demand enterprise-scale interoperability and comprehensive maintenance programs. Research institutes focus on experimental flexibility and data fidelity to support innovation and validation studies.

How geographic variations across Americas, Europe Middle East & Africa, and Asia-Pacific influence adoption patterns, regulatory priorities, and service delivery models in dose management

Regional dynamics profoundly shape technology adoption, regulatory alignment, and service delivery models in radiation dose management. In the Americas, institutions tend to prioritize integrated solutions that align with stringent regulatory reporting and accreditation requirements, while private and public payers increasingly reward demonstrable safety performance. This drives demand for interoperable systems, comprehensive maintenance contracts, and analytics that support both clinical governance and operational efficiency. Centers of excellence in large metropolitan areas often serve as catalysts for diffusion of novel dose-optimization practices.

In Europe, Middle East & Africa, the landscape is heterogeneous, with high-resource healthcare systems pushing rapid adoption of cloud analytics, advanced CT protocols, and cross-institutional benchmarking. Meanwhile, emerging markets within the region emphasize cost-effective maintenance, localized training, and solutions that can operate in variable infrastructure environments. Regional regulatory bodies and professional societies are intensifying guideline harmonization efforts, which supports broader uptake of standardized dose-tracking approaches.

In Asia-Pacific, rapid expansion of imaging capacity combined with investment in digital health infrastructure is accelerating uptake of both hardware upgrades and software-driven dose management tools. Government-led modernization programs and large-scale hospital networks are adopting centralized analytics and population-level safety initiatives. However, deployment strategies must account for wide variability in clinical practice standards, IT maturity, and workforce training needs to ensure equitable improvements in radiation safety across urban and rural settings.

Competitive landscape analysis emphasizing providers that combine device innovation, interoperable software, and robust service models to advance radiation safety and operational resilience

Key companies shaping the radiation dose management ecosystem deploy a mix of integrated systems, specialized software, and service offerings that emphasize safety, interoperability, and lifecycle support. Market leaders invest in research and development to advance dose reduction techniques, integrate AI-enhanced reconstruction algorithms, and expand remote monitoring capabilities that reduce downtime and improve calibration accuracy. Strategic partnerships between system manufacturers, software vendors, and service providers have become a common route to delivering end-to-end solutions that combine device-level controls with enterprise analytics.

Competitive differentiation increasingly resides in the ability to provide validated clinical workflows, robust training programs, and evidence of successful deployments across diverse clinical environments. Companies that offer modular upgrade paths and vendor-neutral integration capabilities enable healthcare organizations to protect prior investments while modernizing their dose management practices. Additionally, firms that demonstrate clear governance frameworks for data privacy, security, and compliance gain trust among enterprise buyers and health system risk managers.

Smaller, specialized vendors continue to innovate rapidly in niche areas such as pediatric dose optimization, interventional dose monitoring, and cloud-based longitudinal dose registries. These firms often partner with larger system manufacturers to scale distribution and certification efforts. Overall, the competitive landscape rewards a balance of clinical credibility, technical interoperability, and scalable service delivery.

Practical and prioritized actions for healthcare executives to align procurement, training, interoperability, and governance in pursuit of optimized radiation dose management

Industry leaders must pursue a portfolio of actionable initiatives to accelerate meaningful improvements in radiation dose management across institutions. First, prioritize investments in staff training and structured consultancy that embed dose-awareness into everyday imaging workflows and support continuous protocol refinement. Training programs should be hands-on, role-specific, and reinforced through competency assessments and periodic audits.

Second, adopt an interoperability-first procurement posture that favors solutions with open APIs and standardized data models to facilitate integration with electronic health records and vendor-neutral archives. This reduces vendor lock-in and enables enterprise-wide dose governance. Third, consider hybrid deployment strategies that leverage cloud-based analytics for population-level insights while retaining on-premise controls where data residency or latency concerns are paramount.

Fourth, negotiate service agreements that emphasize preventive maintenance, remote diagnostics, and software update pathways to extend equipment life and reduce unplanned downtime. Fifth, implement robust governance mechanisms for data security, patient consent, and audit trails to maintain trust and compliance. Finally, embed cross-disciplinary leadership teams-comprising radiology, medical physics, IT, and procurement-to ensure that technology adoption aligns with clinical objectives, budgetary constraints, and regulatory responsibilities.

Comprehensive mixed-methods research approach combining expert interviews, technology assessments, and regulatory analysis to validate findings and support practical implementation

This research leverages a mixed-methods approach combining qualitative expert interviews, technology assessments, regulatory reviews, and secondary literature synthesis to ensure methodological rigor and relevance. Primary inputs include structured interviews with clinical leaders, medical physicists, imaging technologists, and procurement specialists to capture frontline perspectives on usability, training needs, and operational constraints. These insights are cross-referenced with product documentation, clinical guidelines, and peer-reviewed studies to validate technical claims and performance characteristics.

Technology evaluations examine system-level architecture, software deployment modalities, and integration capabilities with existing health IT infrastructure. Regulatory and standards reviews focus on regional guidance, reporting expectations, and accreditation criteria that influence adoption decisions. The methodology places particular emphasis on triangulation: findings from interviews are compared against vendor documentation and published evidence to reduce bias and ensure balanced representation of strengths and limitations.

To preserve transparency, methodological limitations and data provenance are documented, and recommendations are framed to reflect practical feasibility. Stakeholders are encouraged to use the methodological appendix to tailor the findings to their own organizational contexts and to request supplementary analyses where more granular segmentation or regional specificity is required.

Synthesis of strategic priorities and practical pathways to embed radiation dose management as a sustained component of clinical quality, safety, and operational resilience

Radiation dose management is now a strategic imperative that spans clinical quality, patient safety, and institutional resilience. The convergence of advanced imaging hardware, AI-enabled optimization, and scalable analytics presents an opportunity to reduce unnecessary exposure while preserving or enhancing diagnostic outcomes. Yet realizing this potential requires deliberate attention to workforce development, interoperability, lifecycle service models, and governance frameworks that protect patient data and ensure regulatory compliance.

Organizations that succeed will be those that adopt a systems perspective: integrating device-level controls with enterprise analytics, embedding training and maintenance into procurement decisions, and aligning technology choices with clinical workflows. Regional variability and economic pressures call for adaptable procurement strategies that balance upfront costs with long-term value in safety, uptime, and clinical performance. Ultimately, by prioritizing actionable measurement, cross-disciplinary collaboration, and continuous improvement, healthcare providers can deliver imaging services that are safer, more efficient, and more trustworthy for patients and clinicians alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Radiation Dose Management Market, by Product

  • 8.1. Services
    • 8.1.1. Maintenance
    • 8.1.2. Training And Consultancy
  • 8.2. Software
    • 8.2.1. Cloud-Based
    • 8.2.2. On-Premise
  • 8.3. System
    • 8.3.1. Ct
    • 8.3.2. Mammography
    • 8.3.3. X-Ray And Fluoroscopy

9. Radiation Dose Management Market, by Delivery Mode

  • 9.1. Cloud-Based
  • 9.2. On-Premise

10. Radiation Dose Management Market, by Application

  • 10.1. Dental Imaging
  • 10.2. Diagnostic Imaging
  • 10.3. Interventional Procedures
  • 10.4. Radiotherapy

11. Radiation Dose Management Market, by End User

  • 11.1. Clinics
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Research Institutes

12. Radiation Dose Management Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Radiation Dose Management Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Radiation Dose Management Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Radiation Dose Management Market

16. China Radiation Dose Management Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agfa HealthCare NV
  • 17.6. Bayer AG
  • 17.7. Bracco Imaging S.p.A.
  • 17.8. Canon Inc.
  • 17.9. FUJIFILM Holdings Corporation
  • 17.10. GE HealthCare LLC
  • 17.11. Guerbet SA
  • 17.12. INFINITT Healthcare Co., Ltd.
  • 17.13. Koninklijke Philips N.V.
  • 17.14. Landauer, Inc.
  • 17.15. Medsquare SA
  • 17.16. Mirion Technologies, Inc.
  • 17.17. Novarad Corporation
  • 17.18. PACSHealth, LLC
  • 17.19. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RADIATION DOSE MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RADIATION DOSE MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY TRAINING AND CONSULTANCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY TRAINING AND CONSULTANCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY TRAINING AND CONSULTANCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY MAMMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY MAMMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY MAMMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY X-RAY AND FLUOROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY X-RAY AND FLUOROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY X-RAY AND FLUOROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DENTAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DENTAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DENTAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY INTERVENTIONAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY RADIOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY RADIOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 145. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 146. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 147. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 148. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. GCC RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 170. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 171. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 172. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. G7 RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 177. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 178. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 179. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 180. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 181. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. NATO RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL RADIATION DOSE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA RADIATION DOSE MANAGEMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)